Gross total resection of glioma with the intraoperative fluorescence- Guidance of fluorescein sodium

International Journal of Medical Sciences

Volumn 9, Issue 8, 2012, Pages 708-714

  Chen, Bo ^a   Wang, Haifeng ^a   Ge, Pengfei ^a   Zhao, Jingwei ^b   Li, Wenchen ^a   Gu, Huizi ^a   Wang, Guangming ^a   Luo, Yinan ^a   Chen, Dawei ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Fluorescein sodium; Glioma; Gross total resection; Neurosurgery

Indexed keywords

FLUORESCEIN SODIUM;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DETERIORATION; FEMALE; GLIOMA; HEALTH STATUS; HEMIPLEGIA; HUMAN; KARNOFSKY PERFORMANCE STATUS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PEROPERATIVE CARE; POSTOPERATIVE CARE; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; STAINING;

ADULT; BRAIN NEOPLASMS; FEMALE; FLUORESCEIN; GLIOMA; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED;

EID: 84868018022     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.4843     Document Type: Article

References (24)

1. Babu R, Adamson C. Fluorescence-Guided Malignant Glioma Resections. Curr Drug Discov Technol. 2012; [Epub ahead of print].
2. Shinoda J, Sakai N, Murase S, et al. Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection. J Neurooncol. 2001; 52: 161-71.
3. Stummer W, Reulen HJ, Meinel T, et al. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery. 2008; 62: 564-76.
4. Tykocki T, Michalik R, Bonicki W, et al. Fluorescence-guided resection of primary and recurrent malignant gliomas with 5-aminolevulinic acid. Preliminary results. Neurol Neurochir Pol. 2012; 46: 47-51.
5. Koc K, Anik I, Cabuk B, et al. Fluorescein sodium-guided surgery in glioblastoma multiforme: a prospective evaluation. Br J Neurosurg. 2008; 22: 99-103.
6. Kabuto M, Kubota T, Kobayashi H, et al. Experimental and clinical study of detection of glioma at surgery using fluorescent imaging by a surgical microscope after fluorescein administration. Neurol Res. 1997; 19: 9-16.
7. Shinoda J, Yano H, Yoshimura S, et al. Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium. Technical note. J Neurosurg. 2003; 99: 597-603.
8. Ichioka T, Miyatake S, Asai N, et al. Enhanced detection of malignant glioma xenograft by fluorescein-human serum albumin conjugate. J Neurooncol. 2004; 67: 47-52.
9. Kuroiwa T, Kajimoto Y, Ohta T. Development of a fluorescein operative microscope for use during malignant glioma surgery: a technical note and preliminary report. Surg Neurol. 1998; 50: 41-9.
10. Buckner JC. Factors influencing survival in high-grade gliomas. Semin Oncol. 2003; 30: 10-4.
11. Litofsky NS, Bauer AM, Kasper RS, et al. Image-guided resection of high-grade glioma: patient selection factors and outcome. Neurosurg Focus. 2006; 20: E16.
12. Hammoud MA, Ligon BL, elSouki R, et al. Use of intraoperative ultrasound for localizing tumors and determining the extent of resection: a comparative study with magnetic resonance imaging. J Neurosurg. 1996; 84: 737-41.
13. Ritz R, Daniels R, Noell S, et al. Hypericin for visualization of high grade gliomas: first clinical experience. Eur J Surg Oncol. 2012; 38: 352-60.
14. Feigl GC, Ritz R, Moraes M, et al. Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring. J Neurosurg. 2010; 113: 352-7.
15. Eljamel MS, Goodman C, Moseley H. ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial. Lasers Med Sci. 2008; 23: 361-7.
16. Willems PW, Taphoorn MJ, Burger H, et al. Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing tumors: a randomized controlled trial. J Neurosurg. 2006; 104: 360-8.
17. Moore GE, Peyton WT, et al. The clinical use of fluorescein in neurosurgery; the localization of brain tumors. J Neurosurg. 1948; 5: 392-8.
18. Diez Valle R, Tejada Solis S, Idoate Gastearena MA, et al. Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience. J Neurooncol. 2011; 102: 105-13.
19. Stummer W, Novotny A, Stepp H, et al. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg. 2000; 93: 1003-13.
20. Okuda T, Kataoka K, Taneda M. Metastatic brain tumor surgery using fluorescein sodium: technical note. Minim Invasive Neurosurg. 2007; 50: 382-4.
21. Panciani PP, Fontanella M, Garbossa D, et al. 5-aminolevulinic acid and neuronavigation in high-grade glioma surgery: results of a combined approach. Neurocirugia (Astur). 2012; 23: 23-8.
22. Dilek O, Ihsan A, Tulay H. Anaphylactic reaction after fluorescein sodium administration during intracranial surgery. J Clin Neurosci. 2011; 18: 430-1.
23. Mineo JF, Bordron A, Baroncini M, et al. Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients. Acta Neurochir (Wien). 2007; 149:245-52.
24. Freyschlag CF, Smolczyk DR, Janzen E, et al. Prolonged administration of temozolomide in adult patients with anaplastic glioma. Anticancer Res. 2011; 31: 3873-7.